PhageEU is proud to celebrate a year of significant growth and increased EU-level recognition for bacteriophage technology in 2025. Highlights from the past six months include the successful launch of the PhageEU Academy and our expert testimony before the SANT Committee on AMR innovation. As we enter 2026 under the leadership of our new President, Michael Fink, we remain dedicated to advancing phage solutions for patients, farmers, and consumers. 

Read our full newsletter to explore our progress and learn how you can join our mission as a corporate or scientific member.